← Return to Third vaccine to boost antibodies against COVID infection?

Discussion
Comment receiving replies
@ladydidehart

How can we as a group of immunocompromised transplant patients advocate for more research/funding of better therapeutics? Since the vaccine provides little or no protection for us we need to know we can have easy access to treatment if we do happen to contract the virus. We can’t continue to live in fear and isolation.

Jump to this post


Replies to "How can we as a group of immunocompromised transplant patients advocate for more research/funding of better..."

Great point!

Here is another study from France, authorized by the French government. https://www.nejm.org/doi/full/10.1056/NEJMc2108861?query=NC "This study showed that administration of a third dose of the BNT162b2 vaccine to solid-organ transplant recipients significantly improved the immunogenicity of the vaccine, with no cases of Covid-19 reported in any of the patients. However, a large proportion of the patients remain at risk for Covid-19. Barrier measures should be maintained, and vaccination of the relatives of these patients should be encouraged." "...given three doses of the messenger RNA vaccine BNT162b2 (Pfizer–BioNTech). The group included 78 kidney-transplant recipients, 12 liver-transplant recipients, 8 lung-transplant or heart-transplant recipients, and 3 pancreas-transplant recipients."